early conceptus |
embryo ectoderm |
embryo endoderm |
embryo mesoderm |
embryo mesenchyme |
extraembryonic component |
alimentary system |
auditory system |
branchial arches |
cardiovascular system |
connective tissue |
endocrine system |
exocrine system |
hemolymphoid system |
integumental system |
limbs |
liver and biliary system |
musculoskeletal system |
nervous system |
olfactory system |
reproductive system |
respiratory system |
urinary system |
visual system |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transcription Start Site | Location | Distance from Gene 5'-end |
Tssr107553 | Chr11:43317019-43317085 (-) | 26 bp |
Tssr107552 | Chr11:43316514-43316522 (-) | 560 bp |
Tssr107551 | Chr11:43315657-43315683 (-) | 1,408 bp |
QTL | Genetic Location* | Genome Location (GRCm39) | Reference | QTL Note |
Blmpf2 | Chr11, 32.13 cM | Chr11:54065670-67078411 | J:100369 | Gene expression analysis was used to identify candidate genes for bleomycin-induced pulmonary fibrorsis QTLs Blmpf1 and Blmpf2. These loci were previously mapped in an F2 cross between susceptible strain C57BL/6J and resistant strain C3Hf/Kam. Blmpf1 maps to 17.4 cM on mouse Chromosome 17 and Blmpf2 maps to 28 cM on mouse Chromosome 11. Genes mapping to the Blmpf1 interval on mouse Chromosome 17 were evaluated for lung mRNA expression in C57BL/6J and C3Hf/Kam animals with and without bleomycin treatment. Genes showing significant expression differences with P<0.001 are H2-D1 (19.09 cM), C4 (18.8 cM), Glo1 (16 cM), H2-Q7 (19.19 cM), H2-K (18.65 cM), Gabbr1 (20.4 cM), Tff2 (17 cM), Notch4 (18.72 cM), and Fkbp5 (13 cM). Genes mapping to the Blmpf2 interval on mouse Chromosome 11 were evaluated for lung mRNA expression in C57BL/6J and C3Hf/Kam animals with and without bleomycin treatment. Genes showing significant expression differences with P<0.001 are Scgb3a1 (25 cM), Trim16, Pttg1, and Gria1 (31 cM). |
Rhdrox1 | Chr11, syntenic | J:306895 | By generating and analyzing reciprocal congenic mice for this locus, the authors demonstrate that the Rhdrox1/Rhdrox2 region indeed determines the sensitivity of hematopoietic stem and progenitor cells to hydroxyurea. The authors verified pituitary tumor-transforming gene 1 (Pttg1; MGI:1353578) as the quantitative trait gene regulating the differential response of hematopoietic stem and progenitor cells to hydroxyurea treatment and which might therefore be linked to the regulation of lifespan. | |
Rhdrox2 | Chr11, syntenic | J:306895 | By generating and analyzing reciprocal congenic mice for this locus, the authors demonstrate that the Rhdrox1/Rhdrox2 region indeed determines the sensitivity of hematopoietic stem and progenitor cells to hydroxyurea. The authors verified pituitary tumor-transforming gene 1 (Pttg1; MGI:1353578) as the quantitative trait gene regulating the differential response of hematopoietic stem and progenitor cells to hydroxyurea treatment and which might therefore be linked to the regulation of lifespan. |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 10/22/2024 MGI 6.24 |
|
|